Literature DB >> 26007265

Urinary tract anomalies in patients with anorectal malformation.

M N Islam1, K Hasina, M S Reza, S M Hasanuzzaman, T Akter, S A Talukder.   

Abstract

Urinary tract anomalies are common associated anomalies in anorectal malformation (ARM) and major contributory factor for high morbidity and mortality in ARM. In this study, urinary tract anomalies were evaluated in 72 patients of ARM (43 high varieties & 29 low varieties) that were admitted in Dhaka Medical College & Hospital (DMCH) during the period of January 2007 to April 2008. In all cases, evaluation was done by ultrasonogram (USG) and voiding cysto-urethrography (VCUG). Intravenous urography (IVU) was done in selected cases. Urinary tract anomalies were found in 20(27.85%) cases of ARM patients. These anomalies were significantly higher 16(37.2%) in high variety of ARM than 4(13.8%) those with low variety of ARM. The pattern of urological anomalies were vesicoureteral reflux (VUR - 35%), hydronephrosis due to PUJ obstruction (25%), posterior urethral valve (PUV - 15%), renal agenesis (10%), duplex ureter (10%) and bladder diverticulum (5%). Before definite management of ARM urological evaluation is essential to prevent renal damage and to reduce the morbidity and mortality.

Entities:  

Mesh:

Year:  2015        PMID: 26007265

Source DB:  PubMed          Journal:  Mymensingh Med J        ISSN: 1022-4742


  2 in total

1.  Comparison of diagnostic accuracy for fistulae at ultrasound and voiding cystourethrogram in neonates with anorectal malformation.

Authors:  Takahiro Hosokawa; Yoshitake Yamada; Yutaka Tanami; Yumiko Sato; Tetsuya Ishimaru; Yujiro Tanaka; Hiroshi Kawashima; Eiji Oguma
Journal:  Pediatr Radiol       Date:  2019-01-21

2.  Risk factors of vesicoureteral reflux and urinary tract infections in children with imperforate anus: A population-based case-control study in Taiwan.

Authors:  Chung-Wei Wu; Chang-Ching Wei; Cheng-Li Lin; Hsiao-Huei Chao; Tse-Chun Wei; Tsung-Hsueh Hsieh; Ching-Yuang Lin
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.